Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBITDA Margin (2016 - 2018)

Historic EBITDA Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 45960.77%.

  • ENDRA Life Sciences' EBITDA Margin changed N/A to 45960.77% in Q1 2018 from the same period last year, while for Dec 2018 it was 146080.47%, marking a year-over-year decrease of 1447651200.0%. This contributed to the annual value of 9971.19% for FY2024, which is 76864800.0% down from last year.
  • Per ENDRA Life Sciences' latest filing, its EBITDA Margin stood at 45960.77% for Q1 2018.
  • In the past 5 years, ENDRA Life Sciences' EBITDA Margin registered a high of 210.52% during Q2 2016, and its lowest value of 45960.77% during Q1 2018.
  • Over the past 3 years, ENDRA Life Sciences' median EBITDA Margin value was 1073.38% (recorded in 2017), while the average stood at 13580.91%.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' EBITDA Margin was -20398800bps (2017), while the steepest drop was -334647400bps (2017).
  • Over the past 3 years, ENDRA Life Sciences' EBITDA Margin (Quarter) stood at 61.85% in 2016, then crashed by -54107bps to 33526.58% in 2017, then plummeted by -37bps to 45960.77% in 2018.
  • Its last three reported values are 45960.77% in Q1 2018, 33526.58% for Q4 2017, and 317.4% during Q3 2017.